Why the study?
Does intravenous clonidine elicit different cardiovascular, psychological, and endocrine responses in patients with panic disorder compared to controls?
Does intravenous clonidine elicit different cardiovascular, psychological, and endocrine responses in patients with panic disorder compared to controls?
Patients with panic disorder exhibit altered central alpha 2-adrenoceptor sensitivity, characterized by increased cardiovascular and decreased sedative and endocrine responses to clonidine.
Answers are grounded in this paper and cite their sources.
Supports hypothesis of altered central alpha-2 sensitivity in panic disorder; hypothesis-generating and should not yet change practice.
The possibility that a disorder of brain alpha 2-adrenoceptor sensitivity might contribute to the etiology of panic disorder was examined using a challenge paradigm with the alpha 2-adrenoceptor agonist clonidine. The cardiovascular, psychological, and endocrine actions of 1.5-microgram/kg clonidine hydrochloride given intravenously were assessed in 16 patients and compared with age- and sex-matched controls. Patients with panic disorder showed an increased fall in blood pressure and decreased sedative and endocrine responses as compared with controls. These results suggest that there may be subsensitivity of some, and supersensitivity of other, brain alpha 2-adrenoceptors in panic disorder. In view of the increased cardiovascular responses seen in the present study and other reports of increased responses to the alpha 2-adrenoceptor antagonist yohimbine, there may exist an increased lability (decreased damping) of cardiovascular control mechanisms in panic disorder. Such a dysfunction could contribute to the symptoms of panic attacks, such as dizziness, palpitations, and faintness.
No takes yet. Share an insight, caveat, or question.
David J. Nutt (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: